- Home
- XPOF vs NGNE Comparison
XPOF vs NGNE Comparison
Compare XPOF & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPOF
- NGNE
- Stock Information
- Founded
- XPOF 2017
- NGNE 2003
- Country
- XPOF United States
- NGNE United States
- Employees
- XPOF N/A
- NGNE N/A
- Industry
- XPOF Services-Misc. Amusement & Recreation
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- XPOF Consumer Discretionary
- NGNE Health Care
- Exchange
- XPOF Nasdaq
- NGNE Nasdaq
- Market Cap
- XPOF 302.9M
- NGNE 325.3M
- IPO Year
- XPOF 2021
- NGNE N/A
- Fundamental
- Price
- XPOF $8.93
- NGNE $19.00
- Analyst Decision
- XPOF Buy
- NGNE Strong Buy
- Analyst Count
- XPOF 7
- NGNE 7
- Target Price
- XPOF $12.93
- NGNE $41.86
- AVG Volume (30 Days)
- XPOF 598.6K
- NGNE 140.1K
- Earning Date
- XPOF 11-06-2025
- NGNE 08-11-2025
- Dividend Yield
- XPOF N/A
- NGNE N/A
- EPS Growth
- XPOF N/A
- NGNE N/A
- EPS
- XPOF N/A
- NGNE N/A
- Revenue
- XPOF $316,841,000.00
- NGNE N/A
- Revenue This Year
- XPOF N/A
- NGNE N/A
- Revenue Next Year
- XPOF $3.45
- NGNE N/A
- P/E Ratio
- XPOF N/A
- NGNE N/A
- Revenue Growth
- XPOF N/A
- NGNE N/A
- 52 Week Low
- XPOF $6.64
- NGNE $6.88
- 52 Week High
- XPOF $18.87
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- XPOF 52.18
- NGNE 44.43
- Support Level
- XPOF $8.10
- NGNE $18.37
- Resistance Level
- XPOF $8.78
- NGNE $20.72
- Average True Range (ATR)
- XPOF 0.36
- NGNE 1.16
- MACD
- XPOF 0.07
- NGNE 0.00
- Stochastic Oscillator
- XPOF 88.71
- NGNE 36.76
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.